SCHEMBL28453574

SCHEMBL28453574

CC(NC(=O)OC(C)(C)C)c1nc2cc(-c3ccncc3F)sc2c(=O)[nH]1

nearest known ligand 0.42

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
▸ AAK1 Q2M2I8 4/20 0.41
▸ CDC7 O00311 8/20 0.37
▸ DBF4 Q9UBU7 8/20 0.37
▸ ROCK1 Q13464 8/20 0.37
▸ CYP17A1 P05093 1/20 0.35
▸ CCNE1 P24864 6/20 0.35
▸ CDK2 P24941 6/20 0.35
▸ LIPG Q9Y5X9 1/20 0.33
▸ ROCK2 O75116 1/20 0.33
▸ CYP3A4 P08684 1/20 0.33
▸ CYP2C9 P11712 1/20 0.33
▸ RAB9A P51151 1/20 0.33
▸ ADORA2B P29275 1/20 0.32
▸ GPR119 Q8TDV5 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21729548 1.00 AAK1 (0.41) AAK1CDC7DBF4ROCK1CYP17A1
SCHEMBL21729525 0.92 AAK1 (0.40) AAK1CDC7DBF4ROCK1CYP17A1
SCHEMBL21729494 0.89 AAK1 (0.45) AAK1CDC7DBF4ROCK1CYP17A1
SCHEMBL28449437 0.89 AAK1 (0.45) AAK1CDC7DBF4ROCK1CYP17A1
SCHEMBL21729496 0.88 AAK1 (0.51) AAK1CDC7DBF4ROCK1CCNE1
SCHEMBL20572091 0.87 CDC7 (0.43) AAK1CDC7DBF4ROCK1CCNE1
SCHEMBL28453573 0.83 CDC7 (0.37) AAK1CDC7DBF4ROCK1CCNE1
SCHEMBL21712590 0.80 CDC7 (0.42) AAK1CDC7DBF4ROCK1CCNE1
SCHEMBL28449434 0.80 CDC7 (0.36) AAK1CDC7DBF4ROCK1CCNE1
SCHEMBL21712655 0.79 CDC7 (0.46) AAK1CDC7DBF4ROCK1CCNE1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112409373-A Substituted [5,6] cyclo-4 (3H) -pyrimidinones as anticancer agents 南京正济医药研究有限公司 2021-02-26 — — CN disclosed
CN-110381950-B Substituted [5,6] cyclo-4 (3H) -pyrimidinones as anticancer agents 南京正济医药研究有限公司 2020-09-04 — — CN disclosed
Send feedback